Clinical Psychiatry News - FDA orders halt to manufacture of unapproved ergotamine drugs
April 1, 2007 -- The Food and Drug Administration has told eight manufacturers and 12 distributors of unapproved ergotamine-containing drugs to stop marketing these...
M2 Presswire - FDA takes action to halt marketing of unapproved ergotamine; Companies ordered to cease manufacturing and distribution of illegal drugs to treat migraine...
March 2, 2007 -- M2 PRESSWIRE-2 March 2007-US FDA: FDA takes action to halt marketing of unapproved ergotamine; Companies ordered to cease manufacturing and...
Internal Medicine News - FDA curbs unapproved migraine drugs
April 1, 2007 -- The Food and Drug Administration has told 8 manufacturers and 12 distributors of unapproved ergotamine-containing drugs to stop marketing the...
Chain Drug Review - FDA action
March 19, 2007 -- The Food and Drug Administration has told 20 companies to stop manufacturing unapproved drug products that contain ergotamine tartrate. Such products...
Pharmaceutical Processing - FDA halts manufacturing of illegal migraine drugs.(Industry News)
April 1, 2007 -- The FDA recently told 20 companies to cease marketing unapproved drug products containing ergotamine tartrate. Ergotamine tartrate products are...
Warning Letter Bulletin - Excellium Pharmaceutical, Fairfield, NJ, Feb. 26
March 1, 2007 -- The firm's Eperbel S Tablets, a drug product containing ergotamine tartrate for the treatment of vascular headaches, was determined to need an NDA to...
Warning Letter Bulletin - Ferndale Laboratories, Ferndale, Ml, Feb. 26, 2007
March 1, 2007 -- The company, a manufacturer of drug products containing ergotamine tartrate, specifically, phenobarbital, ergotamine, and belladonna tablets,...
Warning Letter Bulletin - DSC Laboratories, Muskegon, Ml, Feb. 26
March 1, 2007 -- The agency warned the firm regarding its drug products containing ergotamine tartrate, specifically, caffeine ergotamine, and pentobarbital...
Warning Letter Bulletin - Sandoz, Princeton, NJ, Feb. 26
March 1, 2007 -- The letter stated that the firm was a manufacturer of phenobarbital, ergotamine, and belladonna tablets, which contain ergotamine tartrate. This...
Warning Letter Bulletin - Kaiser Foundation Hospitals, Livermore, CA, Feb. 26
March 1, 2007 -- FDA determined that the firm was marketing Belladonna Alka/Ergotamine and PB (Bellamine S) tablets, a drug product containing ergotamine tartrate....
